Press release
Global Preeclampsia Drugs Market 2024 Size, Share Analysis, Top Players, Outlook And Forecast To 2033 | AbbVie Inc., Pfizer Inc., Johnson & Johnson Co, F. Hoffmann-La Roche Ltd., Merck & Co. Inc
Preeclampsia Drugs Market
The Business Research Company's Preeclampsia Drugs Global Market Report 2024 identifies rising diabetes cases in pregnancy fueling as the major driver for the Preeclampsia Drugs Market's growth in the forecast period. The rise in diabetes cases among pregnant women is expected to propel the growth of the preeclampsia drug market going forward. Diabetes is a metabolic disease that is chronic and characterized by high blood glucose (or blood sugar) levels. Preeclampsia is a harmful pregnancy condition with elevated blood pressure and organ damage. Metformin, a preeclampsia medicine, is widely used in pregnant women with preterm preeclampsia.
The preeclampsia drugs market size has grown rapidly in recent years. It will grow from $1.13 billion in 2023 to $1.25 billion in 2024 at a compound annual growth rate (CAGR) of 10.7%. The growth in the historic period can be attributed to increased maternal health awareness, research and development, neonatal health concerns, early detection.
The preeclampsia drugs market size is expected to see rapid growth in the next few years. It will grow to $1.89 billion in 2028 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to personalized medicine, non-invasive diagnostic tools, targeted therapies, health equity initiatives. Major trends in the forecast period include preventive strategies, patient-centered care, continuous monitoring, regulatory focus.
Download Free Sample Of Preeclampsia Drugs Market Report -
https://www.thebusinessresearchcompany.com/sample_request?id=13025&type=smp
Major competitors in the Preeclampsia Drugs Market are AbbVie Inc., Pfizer Inc., Johnson & Johnson Co, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, Sanofi S.A., Celgene Corp, Thermo Fisher Scientific Inc., AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Takeda Pharmaceuticals Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Siemens Healthcare GmbH, Boehringer Ingelheim Group, Viatris Inc., Baxter International Inc., Teva Pharmaceutical Industries Ltd., Union Chimique Belge SA, Otsuka Pharmaceutical Co. Ltd., Kyowa Kirin Co Ltd., Mallinckrodt Pharmaceuticals Limited, Comanche Biopharma Corp, Genentech Inc., Diabetomics Inc
A key trend in the Preeclampsia Drugs Market includes pursuing innovative drug solutions. Major companies in the preeclampsia medicine market are focusing on developing cutting-edge drug solutions to boost their market position. For instance, in March 2023, Comanche Biopharma Corp., a US-based biopharmaceutical firm, revealed that the Food and Drug Administration (FDA) has approved an investigational new drug (IND) application for CBP-4888 Comanche's unique siRNA treatment to treat preeclampsia. CBP-4888 is a siRNA therapy given subcutaneously and reduces the synthesis of soluble fms-like tyrosine kinase-1 (sFLT1) in the placenta. The placenta's overproduction of the protein sFLT1, which enters the mother's circulation, is the primary cause of preeclampsia. CBP-4888 can alleviate the symptoms of preeclampsia, such as high blood pressure and organ damage and may allow for the safe extension of pregnancy.
Read More On The Global Preeclampsia Drugs Market Report Here:
https://www.thebusinessresearchcompany.com/report/preeclampsia-drugs-global-market-report
The Preeclampsia Drugs Market is segmented -
By Type: Mild Preeclampsia, Severe Preeclampsia
By Treatment: Medication to Lower Hypertension (B.P), Corticosteroids, Anticonvulsants Medication
By Route of Administration: Oral, Parenteral, Other Route of Administration
By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacies, Other Distribution Channels
By End-User: Hospitals, Specialty Clinics, Diagnostic Centers, Other End-Users
By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the Preeclampsia Drugs Market.
The Business Research Company's "Global Preeclampsia Drugs Market Report 2024" provides a thorough understanding of the market across 60 geographies. The report covers market size, growth rate, segments, drivers and trends in every region and country. In addition, the report offers insights on historical and forecast growth, helping players analyze and strategize better.
Explore Buying Options For The Preeclampsia Drugs Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13025
The Table Of Content For The Preeclampsia Drugs Market Include:
1. Executive Summary
2. Preeclampsia Drugs Market Characteristics
3. Preeclampsia Drugs Market Trends And Strategies
4. Preeclampsia Drugs Market - Macro Economic Scenario
5. Global Preeclampsia Drugs Market Size and Growth
……
32. Global Preeclampsia Drugs Market Competitive Benchmarking
33. Global Preeclampsia Drugs Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Preeclampsia Drugs Market
35. Preeclampsia Drugs Market Future Outlook and Potential Analysis
36. Appendix
Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx
Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.
Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Preeclampsia Drugs Market 2024 Size, Share Analysis, Top Players, Outlook And Forecast To 2033 | AbbVie Inc., Pfizer Inc., Johnson & Johnson Co, F. Hoffmann-La Roche Ltd., Merck & Co. Inc here
News-ID: 3327340 • Views: …
More Releases from The Business research company
Evolving Market Trends In The Integrated Geophysical Services Industry: Enhancin …
The Integrated Geophysical Services Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Integrated Geophysical Services Market Size During the Forecast Period?
The integrated geophysical services market has experienced consistent growth in recent years, expected to rise from $2.35 billion in 2024 to…
Global HR Advisory Services Market: Key Trends, Market Share, Growth Drivers, An …
The HR advisory services market report describes and explains the HR advisory services market and covers 2019-2024, termed the historic period, and 2024-2029, 2034F termed the forecast period. The report evaluates the market across each region and for the major economies within each region.
The global HR advisory services market reached a value of nearly $155.74 billion in 2024, having grown at a compound annual growth rate (CAGR) of 4.22% since…
High Voltage Aluminium Electrolytic Capacitors Global Market Report 2025: Size, …
The high voltage aluminum electrolytic capacitors report describes and explains the high voltage aluminum electrolytic capacitors market and covers 2019-2024, termed the historic period, and 2024-2029, 2034F termed the forecast period. The report evaluates the market across each region and for the major economies within each region.
The global high voltage aluminum electrolytic capacitors market reached a value of nearly $4.10301 billion in 2024, having grown at a compound annual growth…
Global Vertical Market Software Market: Key Trends, Market Share, Growth Drivers …
The vertical market software report describes and explains the vertical market software market and covers 2019-2024, termed the historic period, and 2024-2029, 2034F termed the forecast period. The report evaluates the market across each region and for the major economies within each region.
The global vertical market software market reached a value of nearly $152.61027 billion in 2024, having grown at a compound annual growth rate (CAGR) of 12.11% since 2019.…
More Releases for Preeclampsia
Emerging Preeclampsia Drugs Market Trends: Leading Companies In The Preeclampsia …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts
Preeclampsia Drugs Market Size Growth Forecast: What to Expect by 2025?
The market size for drugs used in the treatment of preeclampsia has seen a swift escalation in the recent past. This market is projected to soar from a value of $1.25 billion in 2024 to $1.38 billion in…
Preeclampsia Diagnostics Market Current Status and Future Prospects till 2033
Preeclampsia Diagnostics Market size was valued at USD 1.2 Billion in 2024 and is forecasted to grow at a CAGR of 8.5% from 2026 to 2033, reaching USD 2.4 Billion by 2033.
Preeclampsia Diagnostics Market Outlook and Investment Analysis
Q1: What is the current market outlook for Preeclampsia Diagnostics?
The Preeclampsia Diagnostics Market is experiencing growth due to increasing awareness, advancements in diagnostic technologies, and the rising prevalence of preeclampsia globally. Growing demand…
Preeclampsia Drugs Market Report 2025-2034: Industry Overview, Trends, And Forec …
The Preeclampsia Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Preeclampsia Drugs Market Size and Its Estimated Growth Rate?
In recent times, there has been a swift expansion in the market size of drugs for preeclampsia. The market, which is expected…
Preeclampsia Diagnostics Market | Exploring Current Trends and Growth Status for …
Preeclampsia Diagnostics Market size was valued at USD 1.2 Billion in 2022 and is projected to reach USD 2.5 Billion by 2030, growing at a CAGR of 9.5% from 2024 to 2030.
Preeclampsia Diagnostics Market Outlook and Investment Analysis
What is the current market outlook for Preeclampsia Diagnostics?
The Preeclampsia Diagnostics Market is experiencing growth due to increasing awareness, advancements in diagnostic technologies, and the rising prevalence of preeclampsia globally. Growing demand for…
Preeclampsia Diagnostics Market Forecast Report 2032
Preeclampsia Diagnostics Market By Test Type (Blood Test, Urine Test, Others), By Product & Services (Instruments, Reagents & Consumables, Services), By End-User (Hospitals, Diagnostic Centers, Others) - Growth, Share, Opportunities & Competitive Analysis, 2024 - 2032
The preeclampsia diagnostics market [https://www.acutemarketreports.com/report/preeclampsia-diagnostics-market] is expected to grow at a CAGR of 4.1% during the forecast period of 2024 to 2032. This growth will be driven by developments in the discovery of biomarkers, the…
Preeclampsia Market Size, Share, Trends, Report and Forecast 2024-2032
The preeclampsia market size is anticipated to grow at a CAGR of 1.8% during the forecast period of 2024-2032, driven by advancements in early detection and monitoring along with growing hypertension prevalence across major markets.
Preeclampsia: Introduction
Preeclampsia is a pregnancy complication characterized by high blood pressure and signs of damage to organ systems, often the kidneys. It usually occurs after 20 weeks of pregnancy in women whose blood pressure had been…
